Literature DB >> 20576804

Blood pressure control in chronic kidney disease: is less really more?

Julia B Lewis1.   

Abstract

BP control is critical in the treatment of patients with chronic kidney disease. Recent guidelines now recommend a BP goal of <130/80 mmHg. Clinical trials using a randomized, intention-to-treat design have not established the benefits of this goal; rather, observational data and secondary or subgroup analyses drove the development of the new guidelines. A variety of observations suggest potential adverse events associate with achieving too low a BP in patients with chronic kidney disease, and ongoing randomized trials will have to establish the benefits or risks of meeting this goal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576804     DOI: 10.1681/ASN.2010030236

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  31 in total

1.  Approach to cardiovascular disease prevention in patients with chronic kidney disease.

Authors:  Cristina Karohl; Paolo Raggi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Prognosis of CKD patients receiving outpatient nephrology care in Italy.

Authors:  Luca De Nicola; Paolo Chiodini; Carmine Zoccali; Silvio Borrelli; Bruno Cianciaruso; Biagio Di Iorio; Domenico Santoro; Vincenzo Giancaspro; Cataldo Abaterusso; Ciro Gallo; Giuseppe Conte; Roberto Minutolo
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 8.237

Review 3.  Hypertension in 2010: Blood pressure and the kidney.

Authors:  Luis M Ruilope
Journal:  Nat Rev Nephrol       Date:  2011-02       Impact factor: 28.314

Review 4.  What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?

Authors:  Yazan Khouri; Susan P Steigerwalt; Mershed Alsamara; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

5.  Identifying the optimal blood pressure target for ideal health.

Authors:  Xianglin Zhang; Fangfang Fan; Yong Huo; Xiping Xu
Journal:  J Transl Int Med       Date:  2016-04-14

6.  Meaningful measurement: developing a measurement system to improve blood pressure control in patients with chronic kidney disease.

Authors:  Jeffrey O Greenberg; Nirav Vakharia; Lara E Szent-Gyorgyi; Sonali P Desai; Alexander Turchin; John Forman; Joseph V Bonventre; Allen Kachalia
Journal:  J Am Med Inform Assoc       Date:  2013-01-23       Impact factor: 4.497

Review 7.  Aging and antihypertensive medication-related complications in the chronic kidney disease patient.

Authors:  Zachary A Marcum; Linda F Fried
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-09       Impact factor: 2.894

Review 8.  Pros and Cons of Intensive Systolic Blood Pressure Lowering.

Authors:  Holly Kramer; Richard Cooper
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

Review 9.  Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.

Authors:  Rakesh Malhotra; Hoang Anh Nguyen; Oscar Benavente; Mihriye Mete; Barbara V Howard; Jonathan Mant; Michelle C Odden; Carmen A Peralta; Alfred K Cheung; Girish N Nadkarni; Ruth L Coleman; Rury R Holman; Alberto Zanchetti; Ruth Peters; Nigel Beckett; Jan A Staessen; Joachim H Ix
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

10.  Chronic kidney disease: blood-pressure targets in chronic kidney disease.

Authors:  Anil K Bidani; Karen A Griffin
Journal:  Nat Rev Nephrol       Date:  2010-12-21       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.